Mr Joel Abramowitz, - Medicare Urology in Jersey City, NJ

Mr Joel Abramowitz, is a medicare enrolled "Urology" physician in Jersey City, New Jersey. He graduated from medical school in 1976 and has 48 years of diverse experience with area of expertise as Urology. He is a member of the group practice Sovereign Medical Group Llc and his current practice location is 142 Palisade Ave, Suite 101, Jersey City, New Jersey. You can reach out to his office (for appointments etc.) via phone at (201) 656-4104.

Mr Joel Abramowitz is licensed to practice in New Jersey (license number 25MA04155500) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1356429377.

Contact Information

Mr Joel Abramowitz,
142 Palisade Ave, Suite 101,
Jersey City, NJ 07306
(201) 656-4104
(201) 656-9178



Physician's Profile

Full NameMr Joel Abramowitz
GenderMale
SpecialityUrology
Experience48 Years
Location142 Palisade Ave, Jersey City, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mr Joel Abramowitz graduated from medical school in 1976
  NPI Data:
  • NPI Number: 1356429377
  • Provider Enumeration Date: 11/01/2006
  • Last Update Date: 05/07/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 1153490552
  • Enrollment ID: I20080527000000

Medical Identifiers

Medical identifiers for Mr Joel Abramowitz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1356429377NPI-NPPES
0738701MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 25MA04155500 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Carepoint Health-christ HospitalJersey city, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Sovereign Medical Group Llc145653539219

News Archive

Public and private SARS-CoV-2 T cell receptors may be crucial for pan-coronavirus vaccines

Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.

Opinions: Harper and global health; Health workers in developing countries; Funding commitments; DDT, GMO use

Canadian Prime Minister Stephen Harper "can use the relatively intimate setting of the G8's Muskoka meeting to press for a renewal of the G8's commitment to better health for Africans, and help the developed world be truly accountable for its promises," the Globe and Mail writes in an editorial. "The G8's failure to fully fund the historic aid commitments to Africa it made at the 2005 Gleneagles summit" puts the future success of the developing world at risk, the editorial states.

WHO Member States designate 2021 as the 'International Year of Health and Care Workers'

Member States at the resumed virtual, 73rd World Health Assembly, recognizing the dedication and sacrifice of the millions of health and care workers at the forefront of the Covid-19 pandemic, unanimously designated 2021 as the International Year of Health and Care Workers.

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.

WHO admits target on AIDS drugs may be unrealistic

In its Annual World Health Report 2004, the WHO said that more donor funds than ever before, at least $20.5bn (£11.5bn; 17.3bn), are available for AIDS relief in the world's poorest countries, but a huge concerted effort will be needed to get antiretroviral drugs to millions of people who need them before it is too late.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Joel Abramowitz allows following entities to bill medicare on his behalf.
Entity NameSovereign Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710282082
PECOS PAC ID: 1456535392
Enrollment ID: O20110418000519

News Archive

Public and private SARS-CoV-2 T cell receptors may be crucial for pan-coronavirus vaccines

Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.

Opinions: Harper and global health; Health workers in developing countries; Funding commitments; DDT, GMO use

Canadian Prime Minister Stephen Harper "can use the relatively intimate setting of the G8's Muskoka meeting to press for a renewal of the G8's commitment to better health for Africans, and help the developed world be truly accountable for its promises," the Globe and Mail writes in an editorial. "The G8's failure to fully fund the historic aid commitments to Africa it made at the 2005 Gleneagles summit" puts the future success of the developing world at risk, the editorial states.

WHO Member States designate 2021 as the 'International Year of Health and Care Workers'

Member States at the resumed virtual, 73rd World Health Assembly, recognizing the dedication and sacrifice of the millions of health and care workers at the forefront of the Covid-19 pandemic, unanimously designated 2021 as the International Year of Health and Care Workers.

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.

WHO admits target on AIDS drugs may be unrealistic

In its Annual World Health Report 2004, the WHO said that more donor funds than ever before, at least $20.5bn (£11.5bn; 17.3bn), are available for AIDS relief in the world's poorest countries, but a huge concerted effort will be needed to get antiretroviral drugs to millions of people who need them before it is too late.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Joel Abramowitz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr Joel Abramowitz,
142 Palisade Ave, Suite 101,
Jersey City, NJ 07306

Ph: (201) 656-4104
Mr Joel Abramowitz,
142 Palisade Ave, Suite 101,
Jersey City, NJ 07306

Ph: (201) 656-4104

News Archive

Public and private SARS-CoV-2 T cell receptors may be crucial for pan-coronavirus vaccines

Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.

Opinions: Harper and global health; Health workers in developing countries; Funding commitments; DDT, GMO use

Canadian Prime Minister Stephen Harper "can use the relatively intimate setting of the G8's Muskoka meeting to press for a renewal of the G8's commitment to better health for Africans, and help the developed world be truly accountable for its promises," the Globe and Mail writes in an editorial. "The G8's failure to fully fund the historic aid commitments to Africa it made at the 2005 Gleneagles summit" puts the future success of the developing world at risk, the editorial states.

WHO Member States designate 2021 as the 'International Year of Health and Care Workers'

Member States at the resumed virtual, 73rd World Health Assembly, recognizing the dedication and sacrifice of the millions of health and care workers at the forefront of the Covid-19 pandemic, unanimously designated 2021 as the International Year of Health and Care Workers.

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.

WHO admits target on AIDS drugs may be unrealistic

In its Annual World Health Report 2004, the WHO said that more donor funds than ever before, at least $20.5bn (£11.5bn; 17.3bn), are available for AIDS relief in the world's poorest countries, but a huge concerted effort will be needed to get antiretroviral drugs to millions of people who need them before it is too late.

Read more News

› Verified 5 days ago


Urology Doctors in Jersey City, NJ

Elliot Shulman, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2255 Kennedy Blvd, Jersey City, NJ 07304
Phone: 201-433-1057    Fax: 201-435-2716
John H. Hajjar, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 631 Grand St, Jersey City, NJ 07304
Phone: 201-803-2573    Fax: 201-791-6585
Yale Shulman, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2255 John F Kennedy Boulevard, Jersey City, NJ 07304
Phone: 201-433-1057    Fax: 201-435-2716
Dr. John Joseph Hosay Jr., M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2555 Kennedy Blvd., Jersey City, NJ 07304
Phone: 201-433-9666    Fax: 201-432-9647
Elliot Gideon Steigman, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 142 Palisade Ave, Ste 211, Jersey City, NJ 07306
Phone: 201-435-2244    Fax: 201-222-7733
Jose Florante Justiniane Leyson, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 562 Westside Ave, Jersey City, NJ 07304
Phone: 201-434-7800    Fax: 201-434-6715

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.